-
2024-516728-32-00
10
2021-10-29
Indolent Systemic Mastocytosis and SSM
-
2024-511651-17-00
4
2021-09-21
Myelodysplastic syndrome
-
2024-514765-19-01
4
2021-08-12
Lynch syndrome, which is increasing the risk of developing colorectal
-
2024-510615-29-00
5
2021-05-24
Chronic active antibody-mediated rejection in kidney transplant recipi
-
2022-501874-21-00
6
2020-12-15
Takotsubo syndrome
-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
-
2022-501456-28-00
5
2020-07-20
atypical teratoid/rhabdoid tumours (ATRT)
-
2022-501050-11-01
10
2020-07-13
Acute Lymphoblastic Leukaemia
-
2024-511053-22-00
4
2020-05-04
Primary sclerosing cholangitis (PSC)
-
2022-501454-11-00
5
2020-02-05
standard risk ALK-positive anaplastic large cell lymphoma (ALCL)
-
2024-517387-37-00
4
2019-12-12
Small abdominal aortic aneurysm (AAA) under active surveillance; 30-49
-
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
-
2023-506857-40-00
5
2019-01-08
Prostate Cancer
-
2022-501254-10-00
5
2018-08-24
Advanced tumors
-
2024-512657-24-00
10
2014-03-27
Acute Lymphoblastic Leukaemia
-
2024-515626-92-00
4
2013-10-18
recurrent/progressive medulloblastoma, ependymoma and atypical teratoi
-
2024-518254-16-00
5
2013-03-01
Acute Myeloid Leukemia (Pediatric 0-18 years)
-
2023-505829-14-00
5
2026-06-02
First recurrence glioblastoma
-
2025-522598-12-00
10
2025-12-17
Untreated Metastatic Pancreatic Ductal Adenocarcinoma
-
2025-520520-17-00
5
2025-09-05
Heterozygous familial hypercholesterolaemia
-
2024-517422-25-00
5
2025-05-22
Metastatic Castration-resistant Prostate Cancer (mCRPC)
-
2024-512925-95-00
5
2025-05-16
Advanced/Metastatic Breast Cancer
-
2023-508055-40-00
6
2025-02-18
Obesity
-
2024-518669-83-00
4
2024-12-05
acute promyelocytic leukemia (APL) in children and adolescents